
Sign up to save your podcasts
Or
Mark McKenna, chairman and CEO at Mirador Therapeutics, speaks with Venrock partner Nimish Shah to discuss his most recent role at Prometheus Biosciences and the beginning of his new company, Mirador. McKenna shares a behind-the-scenes look into leading Prometheus during its acquisition by Merck, why he started Mirador Therapeutics, advice for other CEOs, what he values in a team and more.
4.8
6262 ratings
Mark McKenna, chairman and CEO at Mirador Therapeutics, speaks with Venrock partner Nimish Shah to discuss his most recent role at Prometheus Biosciences and the beginning of his new company, Mirador. McKenna shares a behind-the-scenes look into leading Prometheus during its acquisition by Merck, why he started Mirador Therapeutics, advice for other CEOs, what he values in a team and more.
1,270 Listeners
2,184 Listeners
1,027 Listeners
990 Listeners
1,777 Listeners
2,301 Listeners
3,985 Listeners
123 Listeners
316 Listeners
5,907 Listeners
1,541 Listeners
30 Listeners
146 Listeners
9 Listeners
46 Listeners